News

FUJIFILM invests in VALANX Biotech to advance next generation therapeutics

Read more

XISTA Science Ventures portfolio company Vitrealab Closes $11 Million Series A to Accelerate Development of Quantum Light Chip for AR Displays

Read more

Syntropic Medical has announced the launch of a groundbreaking clinical study testing a new non-invasive brain stimulation method designed to treat depression using light-based therapy.

Read more

With a commitment to innovation, xista is breaking new ground—literally. The beginning of the new year marks the start of construction for xista's latest milestone: a state-of-the-art laboratory and office building. Designed to empower biotech and deep tech startups, this expansion of the xista science park growing infrastructure, reflects xista’s mission to turn groundbreaking science into successful companies.

Read more

Further exciting news from our ecosystem

At xista, we are building while growing: Expanding our team, launching new ventures, forming strategic partnerships, and shaping the infrastructure that will support the next generation of science-driven innovation. Meet our new team members.

Read more

ReCatalyst, a xista portfolio company pioneering next-generation nanocatalysts for the hydrogen economy, has announced the formation of its inaugural Advisory Board a milestone as the company prepares to scale globally.

Read more

Scientific breakthroughs are transforming industries at an unprecedented pace. Yet the key challenge remains: How do we turn cutting-edge research into scalable, investable businesses? deepX, the xista Portfolio Day, brought together investors, industry leaders, and some of Europe’s most promising deep tech startups to explore exactly that.

Read more

xista science ventures is now part of the EIC Trusted Investors Network — joining over 100 leading investors to support deep-tech startups across Europe. The milestone coincides with recent strategic engagements in Brussels, highlighting the growing relevance of science ventures in shaping EU innovation policy.

Read more

A fireside chat with Stephan Huber and Markus Wanko

Read more

On September 19th, the tranquil Campus of the Institute for Science and Technology Austria (ISTA) transformed into a buzzing hub of exchange and innovation at the fully booked bigX 2024. Hosted by ISTA, the innovation ecosystem xista, and the Federation of Austrian Industries (IV), this year’s innovation exchange conference attracted a diverse crowd of visionary researchers from institutions like MIT, Oxford and UMass, and industry pioneers including Novartis, Siemens Energy, and AOP Health under the theme “The Future of AI.”

Read more

xbio alumna Gunpreet Oberoi and her Safe Vascular Access Needle (SVAN) win 3D Printing Life Sciences Award, on top of €100,000 and a ticket to the Falling Walls Science Summit at IECT Summer School Grand Finale.

Read more

With a varied program, xista and VERBUND X showed at Venture Day how the ecosystem in the cleantech sector can be strengthened and what role corporate venture capital plays in this.

Read more

Pre-clinical stage MedTech company Syntropic Medical, has secured a €1.1M grant from the Österreichische Forschungsförderungsgesellschaft. With an additional 7-figure investment from xista science ventures and aws, the start up will demonstrate treatment safety of their non-invasive, non-pharmaceutical treatment of disorders like depression.

Read more

The 2024 Edition of bigX will explore the Future of AI. Get excited by the newest AI breakthroughs and applications showcased by curated industry leaders and academic pioneers from ISTA, MIT, Oxford, and more. Exchange solutions with top-level executives and academic minds.

Read more

As part of the "Innovation Corner" exhibition series, the xista portfolio companies Syntropic Medical and VALANX Biotech are presenting their technologies at the Vienna Museum of Technology. This exciting exhibition runs until December 2024 and offers visitors the opportunity to experience the future of medical technology up close.

Read more

xbio Biotech Enterprise Masterclass celebrates it's second run! On Demo Day cohort 2024 pitched their innovations to 60+ experts from industry and academia. Explore success stories from the xbio Biotech Enterprise Masterclass and discover how xista science ventures supports the next generation of biotech entrepreneurs.

Read more

Securing €63 million in its Series B funding round, Prewave reaches the next milestone in it's remarkable growth journey. Led by Hedosophia, this funding highlights the promising future of the company, that aims to leverage AI to help businesses manage unprecedented supply chain challenges and deliver the world’s first supply chain superintelligence platform. In doing so Prewave adresses increases in reporting and compliance requirements for businesses driven by new regulations in Europe and across the world.

Read more

Our Venture Partner, Bernhard Petermeier, was featured in Cleantech for Europe’s Voices of Innovation series commenting on the impact of AI on the cleantech transition: “AI is a remarkably sharp tool for transforming resource-hungry industries, products, and services by providing data-driven suggestions or making decisions.”

Read more

President of the European Commission Ursula von der Leyen, Finance Minister Brunner, and ISTA President Hetzer join xista MD Markus Wanko to discuss factors in spin-off growth and innovation ecosystem success.

Read more

xista science ventures hosted it's much-anticipated “Investors and Portfolio Day” centered around the theme “Shaping Human and Planetary Health", attracting a diverse audience of 100 investors, funding institutions and entrepreneurs.

Read more

MedTech company secures 7-figure early-stage funding from xista science ventures and Austria Wirtschaftsservice, to develop light stimulation based treatment for mental health disorders such as Major Depressive Disorder.

Read more

G.ST Antivirals reported positive results from Phase I clinical trials on its lead programme, a nasal spray containing 2-Deoxy-D-glucose. Phase II clinical trial funding round led by xista science ventures secured over EUR 6 million.

Read more

ONCO-Boost is a novel class of TLR4 immunostimulants that turn cold tumors into hot ones, increasing the efficacy of other therapies, notably immune-checkpoint inhibitors.

Read more

Swedish startup Rivus Batteries secures €0.5M from xista science ventures, NAVCAP AB, and EIT InnoEnergy to fast-track the deployment of its metal-free battery technology. The company aims to halve the cost and climate footprint of grid-scale energy storage by replacing heavy metal-based electrolytes with organic electrolytes in new flow batteries.

Read more

The investment round was led by xista science ventures, a venture fund focused on scientific advancements, with participation from investors 2bX, Heartfelt, Antler and P3A Ventures. infrared.city is a simulation platform for intelligent and resilient climate-aware design based on Artificial Intelligence. The software provides real-time feedback on the performance of building and urban designs and guides users continuously to a more sustainable outcome. With the raised funds, the startup will accelerate its technology development, and expand its engineering team.

Read more

The investment round was co-led by xista science ventures, a renowned venture fund focused on scientific advancements, and Faber, from its Ocean / Climate Tech fund, with participation from esteemed investor Saber GmbH. Subdron's developed solution enhances Autonomous Underwater Vehicles (AUVs) with cutting-edge technology and artificial intelligence for autonomous inspections of underwater infrastructure such as port facilities and ship hulls. With the raised funds, the startup will open a subsidiary in Porto, accelerate its advanced technology, and expand its engineering team.

Read more

ReCatalyst is developing a nano-tech platform for production of next-generation of intermetallic platinum-alloy PEM fuel cell catalysts with the core mission to enable an optimized usage of platinum group metals. Slovenian Startup ReCatalyst was able to convince an outstanding international syndicate consisting of HTGF, xista science ventures and OCCIDENT, along with Slovenian investors, to invest €1.7 million. The funding will be used to enhance market readiness and accelerate process development for ReCatalyst’s next-generation proton exchange membrane (PEM) fuel cell catalysts, which are expected to grow to a $45 billion market by 2030.

Read more

Prewave, the supply chain risk management and compliance platform used by hundreds of clients, secured 18m Euro in funding in a Series A+ by leading European VC Creandum.

Read more

April 19 2023 – Around the Institute of Science and Technology Austria (ISTA) a new innovation ecosystem is growing, which is changing the innovation and spin off landscape in Austria and beyond.

Read more

Photo of the Sarcura Founding Team

The Austrian deep tech startup Sarcura closes an oversubscribed €7M Seed Plus funding round to develop a next-generation cell therapy manufacturing platform.

Read more

Newly founded Neurotech startup Brightmind.AI, led by founders Florian Lerchbammer-Kreith and Tamara Gerbert, has announced a foundational pre-seed investment in the company by venture fund IST cube.

Read more

The round will enable the startup to scale its platform, continue to grow its customer base and expand its European footprint

Read more

With financial support from IST cube, AWS, the TESS Research Foundation and the Foundation for USP7-related diseases, Neurolentech is well equipped to close in on new therapeutic targets for severe brain disorders

Read more

Pitch your idea

Investment process

1. Share your Information

Use the form to tell us about your startup. Our team will review the details provided and will get back to you as soon as possible. If you meet the required criteria, we’ll plan together the next steps of your funding journey.

2. Start the financing process

We start by inviting you to a meeting and gather more information relevant to conducting a due diligence process, evaluating your business plans, growth strategy, and financial forecasts. Together, we analyze and determine the essential details and deal structure to meet your unique financing requirements.

3. Raise capital

If we invest, we will likely lead your funding round and will help you to fill your round and guide you through the process. From round preparations to execution, our team is here to support you, ensuring a smooth and successful experience.

4. Go beyond financing

We will be your partner in everything you encounter while executing your plans. We offer continuous support and guidance as we firmly believe long-term succes is a shared mission.